Court of Justice (Fourth Chamber) 21 March 2019, C-443/17 (Abraxis Bioscience LLC v Comptroller General of Patents.)

JUDGMENT OF THE COURT (Fourth Chamber) 21 March 2019 ( *1 ) (Reference for a preliminary ruling — Medicinal product for human use — Supplementary protection certificate for medicinal products — Regulation (EC) No 469/2009 — Article 3(d) — Conditions for granting — Grant of first authorisation to place the product on the market as a medicinal product — Authorisation covering a product as a